Skip to content

about
services
cell & gene therapy
spotlights
insights
careers
contacts

story
board of directors
environmental, social & governance
principles
services
cell & gene therapy
overview
accelerate research & clinical development
optimize next-gen manufacturing
drive commercial success
resources
spotlights
insights
careers
contacts

TPG Invests $75 Million into Precision For Medicine – PharmaLive

PMG Staff2015-12-22T16:03:52-05:00News|

PharmaLive covers TPG’s significant investment in Precision Medicine Group

Share

facebook twitter linkedin Email

FEATURED

Precision for Medicine Acquires Baseline Controls, Expanding the Company’s End-to-End Manufacturing Solutions for Life Science Companies

Recent Posts

Event: Cell & Gene Day, 2024
Conference: Meeting on the Med, 2024
Conference: Gene Therapy for Rare Disorders (GTRD), 2024
Simon Fleming Joins Precision
Article: Scrip Asks…What Does 2024 Hold For Biopharma? Part 3: Manufacturing And Supply

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

services
careers
environmental, social & governance
contacts
Aetna MRF

© Precision Medicine Group, LLC.
All Rights Reserved.

Privacy Policy GDPR